We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lung Collectins Both Enhance and Suppress Immune Response

By Biotechdaily staff writers
Posted on 14 Oct 2003
Researchers have shown that the two lung collectins, surfactant proteins A and D (SP-A and SP-D), act in a dual manner to enhance or suppress inflammatory mediator production depending on binding orientation.

Collectin (collagen-like lectin) is a subgroup of C-type (i.e., calcium-dependent) animal lectins characterized by the presence of collagen-like sequences (Gly-Xaa-Yaa triplet). More...
The collectins include three serum proteins, mannan-binding protein (MBP), bovine conglutinin and bovine collectin-43 (CL-43), and two lung surfactant proteins (SP-A and SP-D). The collectins bind to terminal nonreducing sugar residues, mannose, GlcNAc, fucose, and glucose. SP-D binds to maltose. They play important roles in innate immunity without involvement of antibodies.

Surfactant proteins A and D are composed of two regions; a globular head domain that binds pathogen-associated molecular patterns (PAMPs, conserved cell-surface structures that are unique to bacteria and are recognized by the innate sector of the immune system) and a collagenous tail domain that initiates phagocytosis.

Investigators at National Jewish Medical and Research Center (Denver, CO, USA; www.njc.org) working with mice found that SP-A and SP-D bind PAMPs through their globular heads to initiate a signaling pathway that blocks proinflammatory mediator production. In contrast, their collagenous tails stimulate proinflammatory mediator production through binding to calreticulin/CD91. These findings were published in the October 3, 2003, issue of Cell.

"The lung collectins can effectively discriminate between conditions in the lung that warrant an immune response and those that do not,” explained senior author Dr. Peter Henson, professor of pediatrics at National Jewish Medical and Research Center. "They do this with a clever mechanism, inhibiting the immune response with one end of their structure and promoting it with the other. These findings should help clarify confusion about the lung collectins. Lung collectins play not one role, but two as they protect the lung not only from harmful pathogens, but also from harmful overreaction by the immune system.”



Related Links:
National Jewish Medical and Research Center

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Hematology Consumables
Bioblood Devices
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.